BioStem Technologies, Inc.
BSEM
$4.38
-$0.46-9.60%
OTC PK
| 06/30/2025 | 03/31/2025 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -108.98% | 37.61% | 520.51% | 520.51% | 325.34% |
| Total Depreciation and Amortization | 0.89% | 50.48% | 77.32% | 77.32% | 47.04% |
| Total Amortization of Deferred Charges | -81.97% | 19.38% | 200.79% | 200.79% | -- |
| Total Other Non-Cash Items | 76.19% | -40.30% | -269.49% | -269.49% | -28.07% |
| Change in Net Operating Assets | 328.59% | 59.07% | 1,764.05% | 1,764.05% | -763.89% |
| Cash from Operations | -14.57% | 635.10% | 2,519.47% | 2,519.47% | 721.78% |
| Capital Expenditure | -103.68% | -1,228.23% | -27.52% | -27.52% | -420.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -103.68% | -1,228.23% | -1,325.55% | -1,325.55% | -419.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -260.63% | 73.76% | 49.75% | 49.75% | -158.36% |
| Issuance of Common Stock | -- | -86.68% | 41.84% | 41.84% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -260.63% | 50.36% | -115.91% | -115.91% | -122.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.66% | 851.14% | 3,859.42% | 3,859.42% | 3,286.01% |